MGINX
Price
$10.64
Change
-$0.01 (-0.09%)
Updated
Sep 20 closing price
PBAKX
Price
$14.02
Change
-$0.00 (-0.00%)
Updated
Sep 20 closing price
Ad is loading...

MGINX vs PBAKX

Header iconMGINX vs PBAKX Comparison
Open Charts MGINX vs PBAKXBanner chart's image
DWS Global Macro Inst
Price$10.64
Change-$0.01 (-0.09%)
VolumeN/A
CapitalizationN/A
BlackRock Tactical Opportunities K
Price$14.02
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MGINX vs PBAKX Comparison Chart
Loading...
VS
MGINX vs. PBAKX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGINX is a StrongBuy and PBAKX is a Buy.

FUNDAMENTALS
Fundamentals
PBAKX has more cash in the bank: 2B vs. MGINX (183M). PBAKX pays higher dividends than MGINX: PBAKX (11.15) vs MGINX (1.75). MGINX was incepted earlier than PBAKX: MGINX (29 years) vs PBAKX (8 years). PBAKX is a more actively managed with annual turnover of: 172.00 vs. MGINX (48.00). MGINX has a lower initial minimum investment than PBAKX: MGINX (1000000) vs PBAKX (5000000). MGINX annual gain was more profitable for investors over the last year : 11.97 vs. PBAKX (3.53). PBAKX (22.22) and MGINX (21.77) have equivalent 5 years return.
MGINXPBAKXMGINX / PBAKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years8 years-
Gain YTD7.6425.493139%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets183M2B9%
Annual Yield % from dividends1.7511.1516%
Returns for 1 year11.973.53339%
Returns for 3 years9.2110.1990%
Returns for 5 years21.7722.2298%
Returns for 10 years52.19N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NOK4.280.03
+0.71%
Nokia Corp
PROF7.83-0.01
-0.13%
Profound Medical Corp
SHEN15.60-0.23
-1.45%
Shenandoah Telecommunications Co
ENOV43.67-1.35
-3.00%
Enovis Corp
AIM0.27-0.02
-8.18%
AIM ImmunoTech